Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTG + 3TC for HIV MTCT Prophylaxis in Pregnancy
NCT04808973Phase 3Completed
- Sponsor
- Fundação Bahiana de Infectologia
- Start
- Jul 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dolutegravir, lamivudine in human immunodeficiency virus infection (HIV), sponsored by Fundação Bahiana de Infectologia. Started Jul 2021; status: completed.
02
Drugs
dolutegravirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04808973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04808973.